Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

e-Poster Display Session

91P - Prognostic biomarker of clinical outcome in locally advanced rectal cancer in Chinese patients


22 Nov 2020


e-Poster Display Session


Tumour Site

Colon and Rectal Cancer


Sandy Ho


Annals of Oncology (2020) 31 (suppl_6): S1273-S1286. 10.1016/annonc/annonc355


S.S.K. Ho1, S.S. Hon2, E. Hung3, F.K. Mo1, C. So4, M. Tong1, J.F. Lee2, S. Chu2, D. Ng2, D. Lam1, C. Cho3, T.W. Mak2, S.S. Ng2, J. Suen1, A.W. Chan5, W. Yeung6, B.B.Y. Ma1

Author affiliations

  • 1 Department Of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Cancer Center, Hong Kong Cancer Institute, Prince of Wales Hospital, 852 - Shatin/HK
  • 2 Department Of Surgery, Prince of Wales Hospital, 852 - Shatin/HK
  • 3 Department Of Imaging And Interventional Radiology, Prince of Wales Hospital, 852 - Shatin/HK
  • 4 Faculty Of Medicine, The Chinese University of Hong Kong, 852 - Shatin/HK
  • 5 Department Of Anatomical And Cellular Pathology, Prince of Wales Hospital, 852 - Shatin/HK
  • 6 Private Practice In Clinical Oncology, Private oncologist, 852 - Hong Kong/HK


Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 91P


Neoadjuvant chemoradiotherapy (NCRT) is one of the standard treatments for locally advanced rectal cancer (LARC), where pathological complete response (ypCR) has been traditionally used as a surrogate survival endpoint. A relatively new biomarker known as the Neoadjuvant Rectal (NAR) score has been consistently shown to correlate with survival in clinical studies. NAR score is a composite endpoint combining clinical and pathological staging information obtained before and after NCRT which warrants validation in local population. The main objective of this study is to investigate the factors that may influence the achievement of ypCR, such as age, sex, tumour stage and location, presence of threatened CRM and extramural vascular invasion (EMVI) as well as tumour down-staging. Other objectives are to validate the prognostic significance of NAR score and to investigate any factors that are associated with a lower score.


The data of patients with LARC who received NCRT at the Prince of Wales Hospital between August 2006 to October 2018 were retrospectively analyzed. Chi-square or Fisher’s Exact Test was used to determine any correlation between categorical variables and logistic regression for continuous variables. Cox regression was used to determine any interactions between covariates and Kaplan-Meier method for survival analysis.


Of the 193 patients who had optimal response to NCRT and surgery, the mean age was 62 and the male-to-female ratio was 2.94: 1. Tumour down-staging was the only independent prognostic factor which predicted ypCR (p<0.0001). NAR score was associated with overall survival (OS) (hazard ratio, HR=1.042, 95% confidence interval, CI: 1.021-1.064, p<0.0001), disease-free survival (DFS) (HR=1.042, 95% CI: 1.022-1.062, p<0.0001), locoregional recurrence-free survival (LRFS) (HR=1.070, 95% CI:1.039-1.102, p<0.0001) and distant recurrence-free survival (DRFS) (HR=1.034, 95%CI: 1.012-1.056, p=0.002). Patients who had ypCR to NCRT was associated with a lower NAR score (p<0.0001), but ypCR was not associated with survival.


NAR score (but not ypCR) is an independent prognostic marker of survival and disease recurrence in a cohort of Chinese patients who underwent NCRT for LARC.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.


Has not received any funding.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.